WuXi Biology is a prominent biotechnology company based in China. Founded in 2015, it is a subsidiary of WuXi AppTec, a leading global pharmaceutical, biotechnology, and medical device open-access capability and technology platform company. The company's headquarters are located in Shanghai, China.

The modern and state-of-the-art headquarters house various research and development facilities, as well as offices for the company's leadership and administrative teams. The location in Shanghai serves as a hub for its global operations. WuXi Biology focuses on providing comprehensive and integrated solutions for the discovery, development, and manufacturing of innovative biologics and novel medicines.

The company offers a wide range of products and services including antibody drug conjugates (ADCs), bispecific antibody development, antibody engineering, protein expression, cell therapy development, gene therapy development, and preclinical and clinical testing services. With a strong global presence, WuXi Biology has established several noteworthy subsidiaries, joint ventures, and partnerships. It has collaborations with renowned biotechnology and pharmaceutical companies worldwide, including leading academic institutions.

Some of its notable partners include Genentech, Immunomedics, and Fosun Kite. WuXi Biology holds a significant market position in the biotechnology industry. The company's global sales and revenue have steadily increased since its establishment, showcasing its growing influence and market presence.

In terms of competition, it competes with other major biotechnology companies like Biogen, Gilead Sciences, and Amgen. In recent years, WuXi Biology has achieved several major milestones and significant events. In 2020, it was recognized with the CRO Leadership Award by Life Science Leader magazine, highlighting its excellence in contract research and development services.

The company has also expanded its service offerings and invested in cutting-edge technologies to enhance its capabilities in the development of novel biologics and therapies. Currently, WuXi Biology continues to innovate and expand its portfolio of services. It has maintained a strong market position and reputation for delivering high-quality solutions to its global clientele.

With ongoing investments in research and development and strategic partnerships, the company aims to further strengthen its position in the biotechnology industry. Not Found